Metabolic consequences of genetic heterogeneity of lipoprotein composition (lipoprotein heterogeneity)
- PMID: 3812212
- DOI: 10.1016/0002-8703(87)90637-5
Metabolic consequences of genetic heterogeneity of lipoprotein composition (lipoprotein heterogeneity)
Abstract
Lipoprotein composition varies among different genetic forms of hyperlipidemia. An increase in hepatic triglyceride (TG) synthesis in subjects with familial hypertriglyceridemia (FHTG) is associated with secretion of large, TG-enriched, very low-density lipoproteins (VLDL), which have an increased affinity for lipoprotein lipase (LPL) in vivo as compared with VLDL from subjects with familial combined hyperlipidemia (FCHL) or from normal subjects. Elevated levels of plasma low-density lipoprotein (LDL) apoprotein B in FCHL are associated with high apoprotein B production rates. The LDL in FCHL is heterogeneous, with a preponderance of an LDL subfraction, which is denser, smaller, and lipid poor as compared with LDL from normal subjects. The more buoyant LDL subfraction in FCHL seems to be catabolized more rapidly than this dense LDL subfraction.
Similar articles
-
Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.Metabolism. 1981 Sep;30(9):856-68. doi: 10.1016/0026-0495(81)90064-0. Metabolism. 1981. PMID: 7266376
-
Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.J Lipid Res. 1983 Feb;24(2):147-55. J Lipid Res. 1983. PMID: 6403642
-
Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression.Arteriosclerosis. 1984 Nov-Dec;4(6):614-24. doi: 10.1161/01.atv.4.6.614. Arteriosclerosis. 1984. PMID: 6508636
-
Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia.Am J Cardiol. 1998 Feb 26;81(4A):43B-46B. doi: 10.1016/s0002-9149(98)00037-x. Am J Cardiol. 1998. PMID: 9526813 Review.
-
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.Am J Cardiol. 2002 Oct 17;90(8A):30i-47i. doi: 10.1016/s0002-9149(02)02749-2. Am J Cardiol. 2002. PMID: 12419479 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous